What are typical transfusion thresholds in preterm neonates, and how can transfusion-related reactions be minimized?

Prepare for the RNC-NICU Test with comprehensive flashcards and multiple-choice questions. Each query includes helpful hints and detailed explanations to boost your confidence and readiness. Start your journey to success now!

Multiple Choice

What are typical transfusion thresholds in preterm neonates, and how can transfusion-related reactions be minimized?

Explanation:
In preterm neonates, a restrictive transfusion strategy is preferred to balance the need for adequate oxygen delivery with the risks of transfusion. The typical target in stable infants is a hemoglobin around 7–8 g/dL or a hematocrit of about 22–25%. Transfusions are more likely to be considered if the infant shows signs of hemodynamic instability, poor oxygen delivery, or significant comorbidities, but unnecessary transfusions are avoided because each unit carries risks such as infection, electrolyte disturbances, volume overload, and transfusion reactions. To minimize transfusion-related reactions, use compatible crossmatching and leukoreduced blood products to decrease febrile and alloimmune reactions. Irradiation of cellular products is used when indicated to prevent transfusion-associated graft-versus-host disease, particularly in neonates or immunocompromised infants. Vigilant infusion monitoring during the transfusion, appropriate product handling, and considering CMV risk with appropriate product selection further help reduce adverse reactions.

In preterm neonates, a restrictive transfusion strategy is preferred to balance the need for adequate oxygen delivery with the risks of transfusion. The typical target in stable infants is a hemoglobin around 7–8 g/dL or a hematocrit of about 22–25%. Transfusions are more likely to be considered if the infant shows signs of hemodynamic instability, poor oxygen delivery, or significant comorbidities, but unnecessary transfusions are avoided because each unit carries risks such as infection, electrolyte disturbances, volume overload, and transfusion reactions. To minimize transfusion-related reactions, use compatible crossmatching and leukoreduced blood products to decrease febrile and alloimmune reactions. Irradiation of cellular products is used when indicated to prevent transfusion-associated graft-versus-host disease, particularly in neonates or immunocompromised infants. Vigilant infusion monitoring during the transfusion, appropriate product handling, and considering CMV risk with appropriate product selection further help reduce adverse reactions.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy